Previous close | 266.10 |
Open | 263.90 |
Bid | 266.60 x 0 |
Ask | 270.30 x 0 |
Day's range | 263.90 - 267.40 |
52-week range | 246.10 - 381.40 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. The Ariel Appreciation fund increased +4.06% in the quarter, trailing the +8.23% and +8.60% returns of the Russell Midcap Value and Russell Midcap indices. Except for real estate, all sectors in the […]
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.